Abstract
Background: Tinospora cordifolia, commonly known as Giloy or Heart-leaved moonseed, is a revered perennial climbing shrub in traditional Ayurveda, widely utilized for its immunomodulatory and rejuvenating properties. Following a global surge in self-prescription as an “immunity booster” during the COVID-19 pandemic, the safety profile of Giloy became the subject of intense international clinical scrutiny.
Objective: To synthesize the clinical evidence regarding the adverse effects of self-consumed Giloy, delineate the scientific debate surrounding its potential hepatotoxicity, and map its contemporary international regulatory status.
Methods: This review aggregates clinical observations, multi-center retrospective cohorts, case series, and toxicological analyses published in prominent peer-reviewed medical and hepatology literature, alongside official safety databases and regulatory directives from global health authorities.
Results: Accumulating clinical evidence in Western and international medical literature has established a probable link between the unmonitored, long-term consumption of raw Giloy preparations and Herb-Induced Liver Injury (HILI). Key findings suggest that Giloy’s potent immunostimulatory properties can trigger or accelerate autoimmune-like hepatitis in genetically susceptible individuals, characterized by elevated transaminases, positive anti-nuclear antibodies (ANA), and distinct histopathological liver tissue changes.
Conversely, traditional medicine frameworks and the Indian Ministry of Ayush contend that true T. cordifolia is safe, attributing reported toxicities to confounding comorbidities, incorrect dosages, or the accidental botanical substitution of the morphologically similar, hepatotoxic look-alike Tinospora crispa.
While the plant is not globally banned by name, proprietary Ayurvedic formulations containing Giloy face strict import blocks and sweeping regulatory restrictions in regions like Canada and Europe due to heavy metal adulteration and lack of standardized safety data, whereas the United States permits its sale strictly as a dietary supplement.
Conclusion: While Giloy remains an approved cornerstone of traditional medicine in India, independent clinical trials and Western medical literature underscore significant risks of liver injury associated with unsupervised self-consumption. Enhanced regulatory standardization, rigorous pharmacovigilance, and clear consumer distinctions between Tinospora species are critical to mitigating safety risks.
Giloy
Giloy in English is commonly known as Heart-leaved moonseed, and its botanical name is Tinospora cordifolia.]
Key Details
| Category | Details |
|---|---|
| Botanical Name | Tinospora cordifolia |
| Common English Names | Heart-leaved moonseed, Giloy |
| Ayurvedic/Sanskrit Names | Guduchi, Amrita |
| Plant Type | A large, perennial, climbing shrub or vine with heart-shaped leaves. |
| Common Uses | Traditionally used in Ayurveda as a rejuvenating (Rasayana) herb to support immunity, digestion, and mild fevers. |
How Giloy Is Prepared (Such as Juice or Powder), Its Precautions and Side Effects
Giloy (Tinospora cordifolia) can be prepared at home using fresh stems or consumed via commercially available over-the-counter options. Because it possesses strong medicinal properties, following proper preparation guidelines and understanding safety precautions is essential.
How Giloy Is Prepared
1. Homemade Giloy Juice (Kadha / Decoction)
The most common way to consume fresh Giloy is by brewing its stem into an aqueous extract.
- Using Fresh Stems: Take a 6-to-9-inch long fresh Giloy stem (roughly the thickness of your small finger). Wash it thoroughly and peel off the thin, papery outer bark.
- Crushing: Cut the green inner stem into small pieces and crush or bruise them lightly using a mortar and pestle to release the juices.
- Boiling: Add the crushed stem to about 2 cups of water in a pot. Boil the mixture on low-to-medium heat until the water reduces to half its original volume (about 1 cup).
- Straining: Strain the warm liquid into a cup. You can add a pinch of black pepper or a teaspoon of honey to mask its bitter taste.
2. Commercial Forms
If fresh stems are unavailable, Giloy is widely distributed in pre-formulated options:
- Giloy Powder (Churna): Made from dried and finely ground stems. The typical adult dose is ½ to 1 teaspoon taken with warm water or honey twice daily, or as directed by an Ayurvedic practitioner.
- Giloy Juice (Packaged): Readily available commercial juices are usually concentrated. Typically, 15–30 mL of juice is diluted in an equal amount of water and consumed on an empty stomach in the morning.
- Tablets / Capsules (Ghanvati): Concentrated extract tablets are highly stable. The standard dose is generally 1 to 2 tablets daily.
Side Effects and Precautions
While Giloy is generally well-tolerated for short-term use, it can cause adverse effects under specific conditions:
- Autoimmune Diseases: Giloy strongly stimulates the immune system. For individuals with autoimmune conditions—such as Rheumatoid Arthritis, Lupus (SLE), Multiple Sclerosis, or Crohn’s disease—an overactive immune response may worsen symptoms.
- Blood Sugar Lowering (Hypoglycemia): Giloy possesses potent anti-hyperglycemic properties. If you take medication for Type 2 Diabetes, combining it with Giloy can cause your blood sugar levels to drop too low. Monitor your glucose closely.
- Pregnancy and Breastfeeding: There is insufficient clinical data evaluating the safety of Giloy during pregnancy or lactation. It is strongly recommended to avoid use during these periods.
- Surgery: Because it impacts blood glucose regulation and immune function, stop taking Giloy at least two weeks before any scheduled surgical procedure.
- Digestive Discomfort: Overuse or high doses of fresh juice can occasionally trigger mild constipation or stomach irritation in sensitive individuals.
Reports of Ill Effects of Giloy in Clinical Trials and Scientific Journals
There are documented reports in peer-reviewed science journals linking the unmonitored consumption of Giloy (Tinospora cordifolia) to Herb-Induced Liver Injury (HILI) or drug-induced liver injury (DILI).
The scientific community has engaged in an intense debate regarding these reports, particularly following the widespread use of Giloy as an “immunity booster” during the COVID-19 pandemic.
Key Research Findings from Scientific Journals
1. Autoimmune-Like Hepatitis
A major multi-centre study published in the prestigious journal Hepatology / Hepatology Communications (2022) pooled data from 13 medical centres across India.
- The Finding: Researchers analyzed 43 patients who developed unexplained acute hepatitis after consuming Giloy.
- The Mechanism: Many patients tested positive for Anti-Nuclear Antibodies (ANA), and liver biopsies showed injury with autoimmune features.
- The Conclusion: Scientists concluded that Giloy’s powerful immune-stimulating properties can inadvertently trigger autoimmune-like hepatitis or unmask a silent, underlying autoimmune chronic liver disease.
2. Case Series on Liver Toxicity
An initial study published in the Journal of Clinical and Experimental Hepatology (2021) highlighted a case series of patients in Mumbai who presented with acute liver injury or liver failure after consuming Giloy.
- The National Institutes of Health (NIH) LiverTox Database has since given Tinospora a high likelihood score (Category A), recognizing it as a well-established cause of clinically apparent liver injury under certain conditions.
- Cases typically present with severely elevated liver enzymes (ALT/AST), fatigue, jaundice, and nausea, surfacing weeks to 6 months after starting the herb.
The Scientific Counter-Argument & Debate
The reports of hepatotoxicity have been heavily debated between hepatologists and traditional medicine researchers, including the Ministry of Ayush (Government of India):
- The Look-Alike Species Confusion (Tinospora crispa): A prominent argument published in journals like Current Drug Safety suggests that patients may have accidentally consumed Tinospora crispa instead of Tinospora cordifolia. T. crispa is a morphologically similar look-alike vine well-documented to be toxic to the liver. However, some hepatologists counter-argued that they confirmed the use of genuine T. cordifolia via DNA analysis in their study subsets.
- Confounding Variables: Critics of the liver-injury studies note that many patients in the case reports had pre-existing comorbidities (like diabetes, thyroid disorders, or fatty liver) and were taking other undisclosed medications. Therefore, they argue a direct, singular causality to Giloy is difficult to isolate.
- Dose & Preparation: Traditional texts specify rigorous processing methods and exact dosages. Many reported cases involved “mindless, self-medicated consumption” of raw, unmeasured home decoctions over prolonged periods, which differs significantly from regulated Ayurvedic practice.
Reports of Ill Effects of Self-Consumed Giloy in Western Science Journals or Medical Literature
Reports of Ill Effects of Self-Consumed Giloy in Western Science Journals or Medical Literature
The medical literature in Western science and international medical journals contains documented case reports and multicenter studies explicitly linking self-consumed Giloy (Tinospora cordifolia) to severe liver injury.
These papers gained prominent traction globally after a surge in unmonitored herbal consumption during the COVID-19 pandemic. The following points summarize what the peer-reviewed literature reveals:
1. Key Peer-Reviewed Journal Publications
Hepatology (Official Journal of the American Association for the Study of Liver Diseases)
A major nationwide, multi-center retrospective study published in Hepatology (2022) analysed 43 patients. The researchers found that more than half of the patients experienced acute worsening of pre-existing chronic liver disease or acute hepatitis after a median of 46 days of self-consuming Giloy.
Cureus Journal of Medical Science / PubMed Central
Case studies published in Western literature (such as a 2023 review in Cureus) track international occurrences. One notable case involved a 50-year-old female in the West with Hashimoto’s thyroiditis who presented with severely elevated liver enzymes (transaminases) after taking a supplement containing Tinospora cordifolia.
Her liver function progressively normalized only after the herb was discontinued and a brief course of steroids was administered.
Journal of Clinical and Experimental Hepatology
Earlier landmark case series from clinicians in Mumbai systematically diagnosed Herb-Induced Liver Injury (HILI) directly stemming from home-brewed or self-prescribed Giloy extracts.
2. Clinical Characterisation of the “Ill Effects”
Western-style hepatology frameworks utilize specific metric tools—such as the RUCAM score (Roussel Uclaf Causality Assessment Method)—which have classified many of these Giloy-induced cases as “probable” or “highly likely” herb-induced toxicities.
The clinical presentations include:
Autoimmune-Like Hepatitis
Because Giloy is a powerful immunostimulant, its self-consumption can overactivate the immune system. The literature shows that in genetically susceptible individuals, this causes the body’s immune cells to attack its own hepatocytes (liver cells), mimicking autoimmune hepatitis.
Unmasking Silent Diseases
Journals note that many individuals who suffered severe outcomes already had “silent” or undiagnosed fatty liver or chronic liver conditions. Self-medicating with Giloy inadvertently “unmasked” and aggressively accelerated these hidden conditions.
Toxic Phytochemicals & Heavy Metals
In the Hepatology multi-center study, toxicological assays of collected patient Giloy samples revealed the presence of clerodane furano-diterpenoids (compounds inherently toxic to liver cells) as well as unacceptably high background levels of heavy metals like lead, arsenic, and mercury.
3. The Scientific Consensus on “Self-Consumption”
A recurring theme across Western medical literature is the danger of unregulated, self-directed dosing.
Traditional Ayurvedic protocols prescribe specific purification steps, exact dosages, and short durations. Medical literature highlights that during the pandemic, the public consumed raw, unmeasured, and concentrated home decoctions (kadhas) for months on end without clinical supervision, triggering idiosyncratic (unpredictable) liver toxicity.
The U.S. National Institutes of Health (NIH) LiverTox Database maintains a dedicated safety profile on Tinospora, warning that its liver injury can range from mild enzyme elevations to acute liver failure requiring transplantation.
Are Herbal Preparations of Giloy Banned in Any Country?
No, herbal preparations of Giloy (Tinospora cordifolia) are not outright banned globally, but they face strict regulatory restrictions and enforcement actions in several countries.
While no country enforces a specific, standalone prohibition targeting the Giloy plant itself, many Western nations heavily restrict or block Ayurvedic formulations containing Giloy through broader food and drug safety regulations.
Regulatory Status by Region
1. Canada and Europe (Strict Import & Sales Bans)
While the plant species is not banned by name, Ayurvedic proprietary medicines and compound herbal preparations—which frequently include Giloy—face sweeping bans and import blocks in Canada and parts of Europe.
- The Reason: These health agencies regulate herbs strictly under food safety or non-prescription drug frameworks. Health Canada and European regulators have repeatedly flagged and banned specific batches of imported Ayurvedic supplements due to the presence of unacceptably high, toxic levels of heavy metals (like lead, mercury, and arsenic) and a lack of standardized safety data.
2. United States (Regulated as a Dietary Supplement)
In the United States, Giloy is legal to buy and sell, but it is strictly classified as a dietary supplement, not a drug.
- Regulatory Stance: The U.S. Food and Drug Administration (FDA) permits single-species Giloy powders and capsules to be sold online and in stores. However, manufacturers are legally barred from claiming that Giloy can “prevent, treat, or cure” any medical condition (such as COVID-19 or diabetes).
- Distinction from Banned Look-Alikes: The FDA has explicit bans on specific toxic herbs like Calamus root (Vacha), but Giloy remains permitted as long as it adheres to dietary supplement labeling laws.
3. India (Fully Approved and Promoted)
In its native country, Giloy is completely legal, highly promoted, and officially backed by the government.
- The Government Position: The Ministry of Ayush (Government of India) has repeatedly issued advisories declaring that genuine Tinospora cordifolia is safe and effective.
- Safety Context: The Indian government maintains that adverse liver reports are largely caused by the accidental substitution of a look-alike toxic plant called Tinospora crispa, or due to incorrect, self-prescribed dosages.
Why Regulators Monitor Giloy Closely
If you are planning to purchase Giloy internationally, be aware that customs authorities often seize or reject these products due to two primary safety risks highlighted in global medical literature:
- Adulteration: Heavy metal contamination introduced during mass manufacturing in poorly regulated facilities.
- Clinical Safety Concerns: Emerging data in international hepatology journals linking prolonged, unmonitored self-consumption to autoimmune-like liver injuries.
Medical Disclaimer
The information provided above is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
Always consult a qualified healthcare provider or a registered medical practitioner before starting any herbal supplement, including Giloy (Tinospora cordifolia), particularly if you have pre-existing liver conditions, autoimmune disorders, diabetes, or are taking prescription medications.
Never disregard professional medical advice or delay seeking it because of something you have read in this literature.
